Soleno Therapeutics Inc (SLNO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 12-2015 | 09-2015 | 06-2015 | 03-2015 | 12-2014 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -15,909 | -13,064 | -9,770 | -11,651 | -13,238 |
| Depreciation Amortization | 108 | 59 | 31 | 15 | 29 |
| Accounts receivable | -156 | -94 | -12 | -8 | 150 |
| Accounts payable and accrued liabilities | 212 | 542 | 401 | 199 | 354 |
| Other Working Capital | 810 | 928 | 778 | 202 | 300 |
| Other Operating Activity | 4,635 | 4,708 | 4,512 | 9,434 | 7,921 |
| Operating Cash Flow | $-10,299 | $-6,921 | $-4,060 | $-1,809 | $-4,484 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -56 | -48 | -16 | -1 | -31 |
| Net Acquisitions | -1,250 | -1,150 | N/A | N/A | N/A |
| Other Investing Activity | -15 | -91 | -15 | 0 | 0 |
| Investing Cash Flow | $-1,321 | $-1,289 | $-31 | $-1 | $-31 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | N/A | 2,591 |
| Common Stock Issued | 5,605 | 5,416 | 4,471 | 4,189 | 10,728 |
| Other Financing Activity | 3,553 | -443 | -807 | -807 | -2,115 |
| Financing Cash Flow | $9,158 | $4,973 | $3,664 | $3,382 | $11,203 |
| Beginning Cash Position | 7,957 | 7,957 | 7,957 | 7,957 | 1,269 |
| End Cash Position | 5,495 | 4,720 | 7,530 | 9,529 | 7,957 |
| Net Cash Flow | $-2,462 | $-3,237 | $-427 | $1,572 | $6,688 |
| Free Cash Flow | |||||
| Operating Cash Flow | -10,299 | -6,921 | -4,060 | -1,809 | -4,484 |
| Capital Expenditure | -56 | -48 | -16 | -1 | -31 |
| Free Cash Flow | -10,355 | -6,969 | -4,076 | -1,810 | -4,515 |